Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: a study of bortezomib and thalidomide.
Saved in:
| Title: | Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: a study of bortezomib and thalidomide. |
|---|---|
| Authors: | Prince, H. M.1 miles.prince@petermac.org, Schenkel, B.2, Mileshkin, L.1 |
| Source: | Leukemia (08876924). Apr2007, Vol. 21 Issue 4, p818-820. 3p. 2 Cartoon or Caricatures. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
